Medicare

Market Access

Medicare drug pricing negotiations: What comes next?

Last month, the US Centers for Medicare and Medicaid Services released the negotiated prices for the first 10 drugs subject to the

Market Access

Drug pricing overhaul sparks tension with industry

Up until recently, political rhetoric targeting the pharma industry had been largely all bark and no bite.

News

J&J's bid to change pay model for Stelara, Xarelto slammed

A US government agency has hit back at a plan by Johnson & Johnson to change the way it pays discounts on drugs to hospitals participating in the 340B programme for healthcare systems s

News

Medicare plans accuse Teva of covering copays for patients

A class action suit has been filed in the US against Teva, claiming that the company illegally subsidised the copays for patients prescribed its multiple sclerosis therapy Copaxone to boost

News

Kamala Harris vows to extend key health reforms to all in US

Vice President Kamala Harris unveiled her economic agenda at a rally on Friday, with a pledge to widen healthcare reforms introduced by President Joe Biden, including Medicare negotiations

News

Vice President Kamala Harris and President Joe Biden in conversation

Biden, Harris 'just getting started' on IRA drug price cuts

In their first joint appearance since Joe Biden withdrew from the Presidential race to be replaced on the Democrat ticket by Kamala Harris, the duo celebrated the long sought-after Medicare

Medicare drug pricing negotiations: What comes next?

Drug pricing overhaul sparks tension with industry

J&J's bid to change pay model for Stelara, Xarelto slammed

Medicare plans accuse Teva of covering copays for patients

Kamala Harris vows to extend key health reforms to all in US

Biden, Harris 'just getting started' on IRA drug price cuts

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

Medicare

Editor's Picks